99 related articles for article (PubMed ID: 19531663)
1. A homogeneous fluorescent live-cell assay for measuring 7-transmembrane receptor activity and agonist functional selectivity through beta-arrestin recruitment.
Hanson BJ; Wetter J; Bercher MR; Kopp L; Fuerstenau-Sharp M; Vedvik KL; Zielinski T; Doucette C; Whitney PJ; Revankar C
J Biomol Screen; 2009 Aug; 14(7):798-810. PubMed ID: 19531663
[TBL] [Abstract][Full Text] [Related]
2. Kappa opioid receptor screen with the Tango beta-arrestin recruitment technology and characterization of hits with second-messenger assays.
Doucette C; Vedvik K; Koepnick E; Bergsma A; Thomson B; Turek-Etienne TC
J Biomol Screen; 2009 Apr; 14(4):381-94. PubMed ID: 19403921
[TBL] [Abstract][Full Text] [Related]
3. G protein-independent cell-based assays for drug discovery on seven-transmembrane receptors.
Verkaar F; van Rosmalen JW; Blomenröhr M; van Koppen CJ; Blankesteijn WM; Smits JF; Zaman GJ
Biotechnol Annu Rev; 2008; 14():253-74. PubMed ID: 18606367
[TBL] [Abstract][Full Text] [Related]
4. Use of the BRET 7TM receptor/beta-arrestin assay in drug discovery and screening.
Heding A
Expert Rev Mol Diagn; 2004 May; 4(3):403-11. PubMed ID: 15137906
[TBL] [Abstract][Full Text] [Related]
5. Monitoring G protein-coupled receptor activation using an adenovirus-based β-arrestin bimolecular fluorescence complementation assay.
Song YB; Park CO; Jeong JY; Huh WK
Anal Biochem; 2014 Mar; 449():32-41. PubMed ID: 24361713
[TBL] [Abstract][Full Text] [Related]
6. Utilization of the Tango beta-arrestin recruitment technology for cell-based EDG receptor assay development and interrogation.
Wetter JA; Revankar C; Hanson BJ
J Biomol Screen; 2009 Oct; 14(9):1134-41. PubMed ID: 19726785
[TBL] [Abstract][Full Text] [Related]
7. beta-Arrestin recruitment assay for the identification of agonists of the sphingosine 1-phosphate receptor EDG1.
van Der Lee MM; Bras M; van Koppen CJ; Zaman GJ
J Biomol Screen; 2008 Dec; 13(10):986-98. PubMed ID: 19036707
[TBL] [Abstract][Full Text] [Related]
8. High-throughput screening of G protein-coupled receptor antagonists using a bioluminescence resonance energy transfer 1-based beta-arrestin2 recruitment assay.
Hamdan FF; Audet M; Garneau P; Pelletier J; Bouvier M
J Biomol Screen; 2005 Aug; 10(5):463-75. PubMed ID: 16093556
[TBL] [Abstract][Full Text] [Related]
9. Beta-arrestin-mediated activation of MAPK by inverse agonists reveals distinct active conformations for G protein-coupled receptors.
Azzi M; Charest PG; Angers S; Rousseau G; Kohout T; Bouvier M; Piñeyro G
Proc Natl Acad Sci U S A; 2003 Sep; 100(20):11406-11. PubMed ID: 13679574
[TBL] [Abstract][Full Text] [Related]
10. Seven-transmembrane receptor signaling through beta-arrestin.
Shenoy SK; Lefkowitz RJ
Sci STKE; 2005 Nov; 2005(308):cm10. PubMed ID: 16267056
[TBL] [Abstract][Full Text] [Related]
11. c-Src regulates clathrin adapter protein 2 interaction with beta-arrestin and the angiotensin II type 1 receptor during clathrin- mediated internalization.
Fessart D; Simaan M; Laporte SA
Mol Endocrinol; 2005 Feb; 19(2):491-503. PubMed ID: 15498833
[TBL] [Abstract][Full Text] [Related]
12. beta-arrestins: traffic cops of cell signaling.
Lefkowitz RJ; Whalen EJ
Curr Opin Cell Biol; 2004 Apr; 16(2):162-8. PubMed ID: 15196559
[TBL] [Abstract][Full Text] [Related]
13. Helix I of beta-arrestin is involved in postendocytic trafficking but is not required for membrane translocation, receptor binding, and internalization.
Dinh DT; Qian H; Seeber R; Lim E; Pfleger K; Eidne KA; Thomas WG
Mol Pharmacol; 2005 Feb; 67(2):375-82. PubMed ID: 15523053
[TBL] [Abstract][Full Text] [Related]
14. Functional specialization of beta-arrestin interactions revealed by proteomic analysis.
Xiao K; McClatchy DB; Shukla AK; Zhao Y; Chen M; Shenoy SK; Yates JR; Lefkowitz RJ
Proc Natl Acad Sci U S A; 2007 Jul; 104(29):12011-6. PubMed ID: 17620599
[TBL] [Abstract][Full Text] [Related]
15. Evolving concepts in G protein-coupled receptor endocytosis: the role in receptor desensitization and signaling.
Ferguson SS
Pharmacol Rev; 2001 Mar; 53(1):1-24. PubMed ID: 11171937
[TBL] [Abstract][Full Text] [Related]
16. Cell-based high-throughput screening assay system for monitoring G protein-coupled receptor activation using beta-galactosidase enzyme complementation technology.
Yan YX; Boldt-Houle DM; Tillotson BP; Gee MA; D'Eon BJ; Chang XJ; Olesen CE; Palmer MA
J Biomol Screen; 2002 Oct; 7(5):451-9. PubMed ID: 14599361
[TBL] [Abstract][Full Text] [Related]
17. Distinct motifs of neuropeptide Y receptors differentially regulate trafficking and desensitization.
Ouedraogo M; Lecat S; Rochdi MD; Hachet-Haas M; Matthes H; Gicquiaux H; Verrier S; Gaire M; Glasser N; Mély Y; Takeda K; Bouvier M; Galzi JL; Bucher B
Traffic; 2008 Mar; 9(3):305-24. PubMed ID: 18088318
[TBL] [Abstract][Full Text] [Related]
18. Activation of MAPK by TRH requires clathrin-dependent endocytosis and PKC but not receptor interaction with beta-arrestin or receptor endocytosis.
Smith J; Yu R; Hinkle PM
Mol Endocrinol; 2001 Sep; 15(9):1539-48. PubMed ID: 11518803
[TBL] [Abstract][Full Text] [Related]
19. Targeting of diacylglycerol degradation to M1 muscarinic receptors by beta-arrestins.
Nelson CD; Perry SJ; Regier DS; Prescott SM; Topham MK; Lefkowitz RJ
Science; 2007 Feb; 315(5812):663-6. PubMed ID: 17272726
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
